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Background: Shigella is a major pathogen responsible for bacillary dysentery, a severe form of shigellosis. Severity
of the disease depends on the virulence of the infecting strain. Shigella pathogenicity is a multi-gene phenomenon,
involving the participation of genes on an unstable large virulence plasmid and chromosomal pathogenicity islands.
Results: A multiplex PCR (mPCR) assay was developed to detect S. flexneri 2a from rural regions of Zhengding
(Hebei Province, China). We isolated and tested 86 strains using our mPCR assay, which targeted the ipaH, ial and
set1B genes. A clinical strain of S. flexneri 2a 51 (SF51) containing ipaH and ial, but lacking set1B was found. The
virulence of this strain was found to be markedly decreased. Further testing showed that the SF51 strain lacked pic.
To investigate the role of pic in S. flexneri 2a infections, a pic knockout mutant (SF301-Δ pic) and two
complementation strains, SF301-Δ pic/pPic and SF51/pPic, were created. Differences in virulence for SF51, SF301-Δ
pic, SF301-Δ pic/pPic, SF51/pPic and S. flexneri 2a 301 (SF301) were compared. Compared with SF301, both SF51 and
SF301-Δ pic exhibited lower levels of Hela cell invasion and resulted in reduced keratoconjunctivitis, with low levels
of tissue damage seen in murine eye sections. The virulence of SF301-Δ pic and SF51 was partially recovered in vitro
and in vivo through the addition of a complementary pic gene.
Conclusions: The pic gene appears to be involved in an increase in pathogenicity of S. flexneri 2a. This gene assists
with bacterial invasion into host cells and alters inflammatory reactions.
Keywords: Shigella flexneri, Multiplex PCR, Clinical isolates, Pic gene, HeLa cell gentamicin protection assay,
Mouse sereny testsBackground
Bacteria of the genus Shigella are fastidious Gram-ne-
gative organisms that cause an estimated 164.7 million
cases of shigellosis annually worldwide, and are respon-
sible for 1.1 million deaths [1]. Shigellosis is an acute in-
testinal infectious disease. Its symptoms range from mild
watery diarrhea to a life-threatening dysenteric syndro-
me with blood, mucus and pus in stools [2-4]. The se-
verity of the disease depends on the virulence of the
infecting strain. Therefore, clinical diagnosis tests for
Shigellosis should not only focus on the determination* Correspondence: xjcheng@shmu.edu.cn; dqu@shmu.edu.cn
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reproduction in any medium, provided the orof the strain’s biochemical and serological types, but also
on the determination of the strain’s virulence. Based on bio-
typing, the Shigella genus contains four species with 48 ser-
otypes (including subgroups). In China, Shigella flexneri 2a
(S. flexneri 2a) is the predominant subgroup [2].
To simultaneously, effectively, and rapidly detect the
pathogen and determine its virulence, three chromosome-
and plasmid-encoded virulence genes (ipaH, ial, and
set1B) [3,5-7] were chosen to assist in the development of
a multiplex PCR (mPCR) assay. ipaH is present on both
the chromosome and on the large Shigella virulence plas-
mid. Therefore, ipaH is considered a stable PCR target for
pathogen identification [8-11]. The ial gene is located in
the cell-entry region of the large virulence plasmid that
encodes an important part of the molecular machinery
required for bacterial invasion and intracellular survival
[4,12-14]. This region is bracketed by insertion-like (IS)
elements IS100 and IS600, with a high tendency for auto-
matic deletion [4,13,15,16]. Detection based on ialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lence but can easily generate false negative results [4,17].
The set1B gene is located on pathogenicity island 1 (PAI-
1) of the chromosome and encodes Shigella enterotoxin 1
subunit B. Enterotoxin 1 causes the watery phase of diar-
rhea in Shigellosis [6,18,19]. Studies have shown that set1B
is present exclusively in S. flexneri 2a [6,18,19]. An mPCR
system should be able to determine, in a single reaction,
whether the genes related to pathogenesis of a particular
Shigella strain are encoded on the chromosome or the
plasmid, and also to determine the serotype of a particular
strain [4,5].
The S. flexneri 2a pic gene, which is located at an un-
stable chromosomal site of S. flexneri 2a PAI-1, is spon-
taneously deleted at a low frequency [20]. Previous
studies have shown that the pic and set1B loci are over-
lapping genes encoded on opposite strands, and set1B
is within pic [21]. The Pic protein is a 116 kDa auto-
transporter protein, secreted by the serine protease
auto-transporter from members of the Enterobacteria-
ceae family [21,22]. To date, pic has only been found in
enteroaggregative Escherichia coli (EAEC), uropathoge-
nic E. coli (UPEC) and S. flexneri 2a. Pic has been shown
to exhibit hemagglutination and mucinolytic activities
in vitro [21-24]. However, it has also been shown that
Pic is unable to elicit a cytotoxic effect in the HT29-C1
and HEp-2 epithelial cell lines [24,25].
The major aims of our study were to detect and deter-
mine the strain of the Shigella pathogen and determine
its virulence. We also investigated whether attenuation
of SF51 virulence correlated to the loss of pic, by con-




All procedures performed on mice were conducted ac-
cording to national (Regulations for the Administration of
Affairs Concerning Experimental Animals, China) and
international guidelines (NIH Guide for the Care and Use
of Laboratory Animals) and were approved by the Insti-
tutional Animal Care and Use Committee (IACUC) of
Shanghai Medical College, Fudan University (IACUC Ani-
mal Project Number 20090601-QU).
Bacterial strains, plasmids, media and growth conditions
Clinical isolates (n = 86) of S. flexneri were isolated from
an epidemic site in Zhengding (Hebei Province, China).
Serotyping of the strains was carried out by the Bacte-
riological Unit at Huashan Hospital (Shanghai, China).
The S. flexneri 2a 301 (SF301; GenBank Accession No.
AE005674) strain was provided by Dr. Jianguo Xu (Chinese
Center for Disease Control and Prevention, Beijing, China).
SF301 was isolated in 1984 from the Changping District ofBeijing. The affected subject exhibited a severe acute clin-
ical manifestation of Shigellosis. The complete genome of
SF301 was sequenced and has since been used as a refer-
ence strain for S. flexneri 2a in China. E. coli ATCC 25922
was provided by Dr. Bijie Hu from Zhongshan Hospital
(Shanghai, China). E. coli SM10 λpir and plasmid pSB890
were provided by Dr. Daoguo Zhou from Purdue Univer-
sity (West Lafayette, IN, USA). The pSC plasmid was
modified from pREP4 (Qiagen, Hilden, Germany), which
contains a p15A origin of replication and a kanamycin re-
sistance gene. E. coli DH5α was purchased from Invitro-
gen (Carlsbad, CA, USA). S. flexneri and E. coli were
grown at 37°C in Luria–Bertani (LB) medium (Oxoid,
Wesel, Germany). All bacterial strains were grown on Sal-
monella–Shigella (SS) agar (Oxoid) before being trans-
ferred to an LB agar plate. Strains were then incubated
overnight at 37°C, then stored at −20°C in LB broth con-
taining 15% glycerol.
Screening of clinical specimens by mPCR
The ipaH, ial, and set1B genes were detected by mPCR
with primers designed according to the sequences of
these genes in SF301 (Table 1) [3,5,7]. Clinical S. flexneri
isolates (n = 86) were tested using mPCR. The mPCR
mixture (20 μL) consisted of 1.8× PCR buffer (3 mM
MgCl2, 130 μM dNTP; Invitrogen), 0.5 μM ial primer,
0.3 μM ipaH primer, 0.3 μM set1B primer, 1 U of Taq
DNA polymerase (Invitrogen), and 10 μL of bacterial
lysate. Thermal cycling conditions involved an initial de-
naturation step at 95°C for 5 min, followed by 30 cycles
of 94°C for 1 min, 56°C for 1 min, and 72°C for 2 min,
and a final extension step at 72°C for 7 min after the
30th cycle.
Plaque formation tests on HeLa cells
Twelve strains containing ipaH, ial and set1B were fur-
ther tested to determine their virulence in HeLa cells
(ATCC CCL-2) using a plaque formation test [26]. HeLa
cells were grown in 24-well tissue culture plates until
they formed semi-confluent monolayers. The culture
medium used was RPMI1640 supplemented with 10%
fetal calf serum (FCS), and 1% penicillin-streptomycin;
and cultures were incubated at 37°C/5% CO2. Cells were
washed three times with phosphate-buffered saline (PBS),
and bacteria added to the semi-confluent HeLa cultures at
a multiplicity of infection (MOI) of 100. After incubating
at 37°C for 90 min, growth medium containing 5% (w/v)
agar and 20 μg/mL gentamicin was poured into the 24-
well plates, then incubated at 37°C/5% CO2 for 72 h. HeLa
cells were inoculated with SF301 as a positive control, and
with E. coli ATCC 25922 as a negative control.
Sequence and analysis of virulence genes on PAI-1 of SF51
SF51 genomic DNA was extracted using a QIAamp
DNA Mini Kit (Qiagen). PCR primers for amplification
Table 1 Sequences of oligonucleotide primers used in this study
Target gene Gene position on SF301 genome
or virulent plasmid pCP301
Primer* Primer sequence (50→30) Length
(bp)
Primers for detection of virulence-associated genes of S. flexneri by mPCR
ipaH 1422225–1422835 ** ipaH-F CCTTGACCGCCTTTCCGATA 611
ipaH-R CAGCCACCCTCTGAGAGTACT
ial 133550–133869*** ial-F CTGGATGGTATGGTGAGG 320
ial-R CCAGGCCAACAATTATTTCC
set1B 3069523–3069669** set1B-F GTGAACCTGCTGCCGATATC 147
set1B-R ATTTGTGGATAAAAATGACG
Primers for amplifying int, orf30, sigA and pic on PAI-1 of S. flexneri 2a
int 3052736–3053998** int-F ATGGCACTGACTGACGCAAA 400
int-R TGCCGATAAAGGGGAAAACG
orf30 3096187–3097975** orf30-F CTTATCACTGAGCGTCTGGT 1,102
orf30-R GTGAAATTCCTGCCTCAATA
sigA 3060437–3064294** sigA-F AGTCATATTACAGGTGGATTAG 1,866
sigA-R TATACTCAGGGTTGCGTTTT
pic 3067737–3070949** pic-F AGAACATATACCGGAAATTC 1,219
pic-R ACCCTGACGGTGAATAAACT
Primers for homologous recombination to construct pic knockout strain




3071850–3072358 ** downpic-F-XbaI CCTCTAGAATTCACTATGGATTCTCCATGAT 517
downpic-R-BamHI AAGGATCCCGTCGTCCGTCTGGCACC






3067737–3070949** pic-pSC-F-PfMlI AAACCATCGAATGGATGCAGGACGATTTCGATGCCCCCGTAGAC 3,213
pic-pSC-R-AclI TTTAACGTTTCAGAACATATACCGGAAATTCGCGTT
*F, forward primer; R, reverse primer.
**SF301 GenBank Accession No. AE005674.
***SF301 large virulent plasmid pCP301 GenBank Accession No. AF386526.
Underlined sequences represent restriction endonuclease sites.
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isolate were designed according to the SF301 sequence.
Amplicons were cloned into a pCR-XL-TOPO vector
using a TOPOW XL PCR Cloning Kit (Invitrogen), and
the inserts were sequenced by Sangon Biotech (Shang-
hai, China) Co. Ltd, then identified using the standard
nucleotide basic local alignment search tool (BLASTn;
NCBI).
Construction of SF301-Δ pic
The upstream and downstream portions of pic were am-
plified by PCR. Primers uppic-F-NotI and uppic-R-XbaI
(Table 1) were used to amplify the upstream fragment of
pic, with primers downpic-F-XbaI and downpic-R-BamHI
(Table 1) used to amplify the downstream fragment. Theamplified downstream fragment of pic was digested with
XbaI and BamHI and ligated into pSB890 which had been
cut with the same restriction endonucleases [27]. We desig-
nated the resulting plasmid pSB890-pic downstream. The
amplified upstream pic fragment was digested with NotI
and XbaI and ligated into pSB890-pic downstream that had
been digested with NotI and XbaI. The resulting vector was
designated pSB890-Δ pic and transformed into E. coli
SM10 λpir cells, then introduced into SF301 through a bac-
terial conjugation test. After culturing on a sucrose LB agar
plate at 22°C, sucrose-tolerant colonies were screened using
Shigella-specific minimal medium [7] and a PCR employ-
ing primers Upuppic-F and Downdownpic-R (Table 1).
The mutant strain with the pic deletion was identified by
sequencing and named SF301-Δ pic.
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and SF51/pPic
A plasmid containing pic was constructed using pSC
modified from pREP4. The pic gene was amplified from
SF301 genomic DNA using PCR. The PCR primers used
were pic-pSC-F-PfMlI and pic-pSC-R-AclI (Table 1). Am-
plicons were inserted into pSC, creating pSC-pic, which
was verified by restriction enzyme digestion and nucleic
acid sequencing. Verified pSC-pic was transformed into
SF301-Δ pic and SF51, resulting in SF301-Δ pic/pPic and
SF51/pPic, respectively.
S. flexneri growth curves
The growth curves of S. flexneri 2a strains were de-
termined by measuring the optical density at 600 nm
(OD600) as described previously [28]. Briefly, overnight
cultures were diluted 1:200 and incubated at 37°C with
shaking (220 rpm). Samples (1 mL) of the bacterial cul-
tures were taken every 30 min over 16 h and OD mea-
sured. Growth curves were created by plotting OD600
against incubation time (h).
S. flexneri HeLa cell invasion assays
S. flexneri cell invasion assays were used to test the viru-
lence of a SF51 clinical strain without set1B, SF301-Δ pic,
wild-type SF301, SF301-Δ pic/pPic and SF51/pPic. The
ability of bacteria to invade HeLa cells was determined
using a gentamicin protection assays [29]. HeLa cells were
grown in 6-well tissue culture plates in DMEM sup-
plemented with 10% FCS and incubated at 37°C/5%
CO2 until they formed semi-confluent monolayers. SF51,
SF301-Δ pic, SF301-Δ pic /pPic, SF51 /pPic and SF301
were individually added to semi-confluent HeLa cells at
an MOI of 100. Bacteria were diluted and plated on LB
agar plates. Colony-forming units (CFUs) were counted
and added to HeLa cells. Plates were centrifuged at
900 × g for 5 min. After incubating at 37°C for 90 min, cells
were washed three times with PBS, and gentamicin added
to the medium at a final concentration of 10 μg/mL. The
mixture was then incubated for 20 min at 37°C. HeLa cells
in each well were lysed with 1 mL of PBS containing 0.1%
Triton X-100 for 10 min at room temperature. Lysates
were diluted and plated onto LB agar plates in triplicate.
Colonies that grew on LB plates were counted. Results
were expressed as the number of bacteria recovered from
gentamicin-treated cells divided by the number of inocu-
lated bacteria added to the cell. Cells inoculated with E. coli
ATCC 25922, an avirulent strain, were the negative con-
trols. Cell invasion assays were performed in triplicate for
each strain, and the assay repeated twice.
Sereny tests and pathohistological examination
A mouse Sereny test was used to evaluate the virulence
of all strains we examined in this study, as described byMurayama [30]. A single red colony of S. flexneri on
Congo red agar [Tryptic soy broth (Oxoid), 1.5% (w/v)
agar and 0.01% (w/v) Congo red] was inoculated into
LB broth at 37°C for 8 h with constant shaking. Female
BALB/c mice (4–5-weeks-old) were infected with 1 ×
108 CFUs per eye (n = 4 eyes, two mice in each group).
Symptoms and signs of keratoconjunctivitis in mice
infected with bacteria were observed at 24, 48, 72, and
96 h post-inoculation [28,30]. Eyes inoculated with E.
coli ATCC 25922 and normal saline (NS) served as the
negative controls. The invasiveness of bacteria was sco-
red according to the following system: ‘−’ indicates no
inflammation, and an infection level score of 0; ‘±’ is in-
dicative of low levels of keratoconjunctivitis, and an in-
fection level score of 0.5; ‘+’ indicates slight conjunctival
inflammation with eyelid edema, and an infection level
score of 1; ‘++’ indicates mild keratoconjunctivitis with
eyelid edema, increased tear film evaporation and periocu-
lar hair loss, and an infection level score of 2; and ‘+++’ in-
dicating fully developed keratoconjunctivitis with eyelid
swelling, periocular hair loss, blepharophimosis, conjunc-
tival follicles and purulent discharge, and an infection level
score of 3. At 24, 48, 72, and 96 h post-inoculation, mice
were euthanized and the eyes removed and fixed in 4%
formalin in PBS (pH 7.2). After hemotoxylin and eosin
(H&E) staining, eye sections were examined using a light
microscope.
Statistical analysis
Experimental data were analyzed with SPSS and compari-
sons made using Student’s t-test. Differences with a P-value
less than 0.05 were considered statistically significant.
Results
Detection of ipaH, ial, and set1B in S. flexneri clinical
isolates
The ipaH gene was detected in all 86 S. flexneri clinical
isolates, whereas ial was detected in 45 isolates (52.3%),
and set1B detected in 69 isolates (80.2%). Amplicons for
ipaH, ial and set1B were not seen from E. coli ATCC
25922 samples. All three genes were detected in the SF301
positive control.
HeLa cell invasion of S. flexneri clinical isolates
Nine isolates in our study contained all three genes, one
SF68 isolate contained ipaH and set1B, one SF51 isolate
had ipaH and ial, and one SF36 isolate contained only
ipaH (Table 2). The nine isolates that contained all three
virulence-associated genes demonstrated high invasive
ability in HeLa cells (>200 plaques/well). In HeLa cells,
SF68 and SF36 were less invasive resulting in 4 and 2
plaques/well, respectively. SF51 lacked set1B but retained
ial, and showed a decrease in invasiveness (20 plaques/
well; Table 2). Using PCR and nucleotide sequencing, it
Table 2 Invasion of HeLa cells by S. flexneri clinical
isolates as determined by plaque formation tests
Gene detected by mPCR Number
of strains
Plaque formation
number (per well)*ipaH ial set1B
+ + + 9 >200±16
+ + - 1 (SF51) 20±5
+ - + 1 (SF68) 4±2
+ - - 1 (SF36) 2±1
* Values represent the mean ± standard deviation of three wells.
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but harbored sigA and other significant open reading
frames (Figure 1).
HeLa cell invasion of SF301 and mutants
The growth curves for SF51, SF301-Δ pic, SF301, SF301-Δ
pic/pPic and SF51/pPic were similar under aerobic growth
conditions (Figure 2). Gentamicin protection tests on
HeLa cells revealed that the cell invasion ratio for clinical
isolate SF51 with standard strain SF301 decreased by 34%,
while the invasion ratio for SF301-Δ pic compared with




















Figure 1 Amplicons from SF51 int, orf30, sigA and pic. Specific amplico
and sigA were amplified from SF51 DNA but pic was not. All four target ge
all PCR products was confirmed by nucleic acid sequencing.abilities were partially recovered by the introduction of pic
into deleted mutant SF301-Δ pic, which increased the
ratio by 31% (to a final cell invasion ratio of 51%,
Figure 3A). The invasion abilities of SF51/pPic increased
by 59% compared with SF51, with cell invasion ratios of
35% and 22%, respectively (Figure 3B). The E. coli ATCC
25922 strain was not found to invade HeLa cells.
Mouse Sereny tests and pathohistological examination
Mouse Sereny tests confirmed the results of the cell in-
vasion tests. Mild presentation of keratoconjunctivitis
was observed 24 h after mice were infected with SF301.
Symptoms included eyelid edema, increased tear film
evaporation and periocular hair-loss that we scored as
either + or ++, with an average infection level score of
1.5. This developed into severe keratoconjunctivitis with
maximal blepharophimosis at 48 h that we rated +++, and
an average infection level score of 2.8. Keratoconjunctival
inflammation continued for 96 h post-inoculation with
SF301 (Figure 4). Both the isolated and constructed pic-
deletion mutants induced lower levels of inflammation in
the eyes of mice than for SF301 (Figure 4). At 48 h post-
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Figure 2 Growth curves for SF301 and the pic mutants (SF51, SF301-Δ pic, SF301-Δ pic/pPic and SF51/pPic).

















































Figure 3 HeLa cell invasion assays for SF301 and the pic mutants. (A) The HeLa cell invasion abilities of SF301, pic knockout mutant of SF301
(SF301-Δ pic), pic complementation of SF301-Δ pic (SF301-Δ pic/pPic) and E. coli ATCC 25922. (B) The invasion abilities of pic complementation of
SF51 (SF51/pPic) compared with clinical isolate SF51. Values are presented as mean ± SD.
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Figure 4 Images of keratoconjunctivitis from mouse Sereny tests for SF301 and pic mutants. *P < 0.05 vs. SF301.
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level scores up to 1.2; for SF51, pathogenicity was rated ±
or + with an average infection level score less than 0.6.
Virulence was partially recovered by introducing the
complementary pSC-pic into the deletion mutants. At
48 h post-inoculation the pathogenicity of SF301-Δ pic/
pPic was rated at + or ++ with an average infection level
score 1.9; SF51/pPic pathogenicity was + or ++ with aver-
age infection level scores of 1.2. At 48 h post-infection, in-
flammatory reactions were not observed in the normal
saline negative controls (−, 0). However, E. coli ATCC
25922 slight edema (±) in a single eyelid at 48 h post-
infection with an average infection level score of 0.3.
Light microscopy assessment at 48 h post-infection
revealed typical symptoms of SF301 infection. These
included limited invasion, corneal epithelial thicken-
ing and loss, along with mild, moderate, or severe ul-
cers. Both pic-deletion mutants showed fewer pathologic
changes following H&E staining compared with SF301
(Figure 5).Discussion
Shigella pathogenicity is a multigenic phenomenon involv-
ing the participation of genes on the unstable large viru-
lence plasmid and chromosomal PAIs [12-14,17,28,31-34].
Mobile genes encode key factors that help Shigella invade
tissue and maintain its intracellular viability [13,17,35-38].
The pathogenicity of the strain decreases markedly once
the mobile genes are deleted [4,32,33].
Several studies have been conducted to detect viru-
lence genes in Shigella by mPCR, targeting ipaH, ial,
and rfc or stx1 for serotype identification [3,5,7,39]. In
2005, Thong [5] first described a new mPCR system to
detect S. flexneri 2a by targeting four virulence genes
(ipaH, ial, set1A and set1B). This mPCR system was able
to determine, in a single reaction, whether genes related
to pathogenesis of a particular Shigella strain are asso-
ciated with the chromosome or plasmid, and whether
the serotype of the particular strain can be grouped
under S. flexneri 2a [4,5]. In our present study, Thong’s
mPCR system was modified to identify S. flexneri 2a
Figure 5 Histological features of mouse corneas following Sereny tests with SF301 and pic mutants. (A, B) Following inoculation with
normal saline, normal corneal epithelium with many layers arranged in an orderly manner can be seen (A: ×50 magnification; B ×400
magnification). (C) After infection with SF301, the corneal epithelium was thinner than that of the control, and vesicular changes (arrowheads)
were observed (×100 magnification). (D) Corneal epithelial edema was observed (arrowheads; ×200 magnification). (E) Polymorphic nuclear
neutrophilic activity was observed (arrowheads; ×200 magnification). (F) Corneal epithelial derangement and detachment were observed
(arrowheads; ×200 magnificaiton). (G) After infection with SF301-Δ pic little damage was observed, but corneal epithelial hyperplasia was noted
(arrowheads; ×200 magnification). (H) After infection with SF51, little damage was observed (×200 magnification).
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genes (ipaH, ial, and set1B). We omitted set1A from the
mPCR system, as both set1B and set1A genes have been
shown to exist in tandem on PAI-1 of the bacterial
chromosome, and they share the same promoter [5,21].
The low prevalence of ial (45/86, 52.3%) verifies that the
cell-entry region on the large virulence plasmid of S.
flexneri is prone to loss or deletion. The high prevalence
of the set1B gene (69/86, 80.2%) verifies that in the rural
regions of Zhengding, the isolated epidemic strain of
Shigella was S. flexneri 2a. All of our mPCR results were
confirmed by serological tests. We confirmed that com-
parable decreases in virulence occur following the dele-
tion of essential elements in the large virulence plasmid
(ipaH and set1B for SF68; and ipaH for SF36) [35-38]. A
clinical SF51 isolate was found to retain ial but had lost
set1B, and demonstrated an obvious decrease in HeLa
cell invasion. This indicated to us that the chromosome
locus around set1B may influence virulence.
The location of set1B is known to be in Shigella PAI-1
[7,20], which exists exclusively in S. flexneri 2a. At least
four major virulence genes are present in PAI-1 (pic,
set1A, set1B, and sigA). The autotransporter SigA exhi-
bits cytopathic effects on HEp-2 cells [40], and the auto-
transporter Pic exhibits hemagglutination and mucinolytic
activities in vitro [20-23,41-43]. Upstream from pic are two
IS elements, IS911 and IS629, followed by pic itself, and
then a perD IS element [21]. This implies that pic can be
spontaneously deleted.
The upstream element int, downstream element orf30,
cytopathic factor gene sigA, and the hemagglutinin genepic on PAI-1 of SF51 were sequenced to verify whether
SF51 lost the whole PAI-1 or only part of the genetic
locus around set1B. Our results revealed that the entire
pic gene on PAI-1 was deleted in this case, whereas other
genes (sigA, int, and orf30) were unaffected (Figure 1).
This result also suggests that a decrease in virulence of
SF51 is not related to sigA, but may be associated with pic
deletion.
To confirm that the decreased virulence phenotype in
SF51 was associated with deletion of pic, we knocked
out pic from the SF301 strain to produce SF301-Δ pic.
Additionally, complementation strains SF301-Δ pic/pPic
and SF51pic/pPic were constructed to demonstrate that
the decreased virulence of SF51 was associated with the
deletion of pic. Using gentamicin protection assays, we
showed that the Hela cell invasion potential of the pic
knockout strains, SF51 and SF301-Δ pic, was decreased
compared with the wild-type SF301 strain. This decreased
virulence was partially recovered by introducing pSC-pic.
Previous studies have demonstrated that purified re-
combinant protein Pic (prepared from E.coli HB101
(pPic1)) is not involved in cytotoxic effects on HT29-C1
and HEp-2 cells [24,25]. However, the findings from our
current study show that both the clinical and cons-
tructed pic-deleted mutants possessed a decreased ten-
dency for cell invasion compared with SF301. Virulence
was partially recovered through the insertion of a com-
plementary pic gene into these deletion mutants. Be-
cause Pic did not elicit cytopathic effects on epithelial
cells, it may be associated with a less efficient interaction
process with host cells, lacking any assistance from
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served by Vidal et al. [44], who examined the EPEC
autotransporter EspC. Purified EspC requires a higher
concentration (300 μg/ml vs. 50 μg/ml for other auto-
transporter cytotoxins) and a longer incubation time (8 h
vs. 1 h for EPEC host cells) to produce the same cytotoxic
effects as other EPEC isolates. Further studies have con-
firmed that EspC translocation into epithelial cells results
in cytopathic effects in HeLa cells, but require participa-
tion of types III and V secretion systems. The mechanism
by which Pic is interacted with epithelial cells remains un-
known and warrants further study. Further, differences in
results observed with Pic regarding decreases in cyto-
pathic effects are likely also associated with other cell
lines. Differences in invasion efficiency between Hela cells
and HEp-2 cells have been observed for Streptococcus pyro-
genes, Campylobacter jejuni and Salmonella typhimurium
[45-47]; however, the reasons for these differences remain
unclear, and further study is required to clarify this.
The mouse Sereny test is commonly used to the test
the invasiveness of Shigella [30]. In our work, the viru-
lence of SF51 and SF301-Δ pic was obviously decreased.
This was partially recovered by the introduction of pSC-
pic into deletion mutants. Our findings support the con-
clusion that pic is associated with the invasion potential
of S. flexneri 2a.
Harrington et al. [42] used a mouse model treated with
streptomycin to show that Pic promotes intestinal co-
lonization by comparing intestinal colonization abilities
of wild-type E. coli 042 and pic mutants (E. coli 042 pic::
aph3 and E. coli 042PicS258A). They demonstrated that
the constructed mutants (E. coli 042 pic::aph3 and E. coli
042PicS258A) contained significant defects that adversely
affected colonization of mice gastrointestinal tracts com-
pared with E. coli 042. Further work by Harrington et al.
suggested that a possible mechanism of promoting intes-
tinal colonization depended on the mucinase activity of Pic.
They also showed that this effect is associated with the
serine protease catalytic residue in Pic. The research of
Harrington et al. supports our findings that Pic is involved
in bacterial invasion ability. Whether a decrease in viru-
lence is associated with the mucinase activity of Pic, or
other biological activities, should be investigated further.
Conclusions
Our findings suggest that pic, located on PAI-1 of S. flex-
neri 2a, plays a role in cell invasion during Shigella
infections. Further work is necessary to elucidate how
Pic affects host-pathogen interactions, and how Pic as-
sists S. flexneri 2a to invade intestinal epithelial cells and
cause cytopathic effects.
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